検索結果

論文投稿実績 | 研究開発活動 | 千寿製薬株式会社

d, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutic...

tion holder is Rexxam Co., Ltd. (hereinafter “Rexxam”). RET-700 is an auto ref-topographer equipped with Auto Refract Keratometer, Topographer, Wavefront, Dry eye analysis (optional) and Meibomian gla...

tion holder is Rexxam Co., Ltd. (hereinafter “Rexxam”). RET-700 is an auto ref-topographer equipped with Auto Refract Keratometer, Topographer, Wavefront, Dry eye analysis (optional) and Meibomian gla...

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical

nce of medical professionals active on the front lines of medicine. Their clinical data provides us with the invaluable insights that accelerate the progress of our basic research. Working in close co...

for BeelineMED” in Japan. MIEr for BeelineMED is capable of sharpening indistinct image files taken with various optical devices by installing image sharpening the algorithm developed by Logic and Des...